(3R,5R,6R,7Z,9E,11E)-13-Chloro-5,6-epoxy-4,16-dihydroxy-3-methyl-11-[2-(2-oxopyrrolidin-1-yl)ethoxyimino]-3,4,5,6,11,12-hexahydro-1H-2-benzoxacyclotetradecin-1-one (308244-21-5)

Identification
Name:	(3R,5R,6R,7Z,9E,11E)-13-Chloro-5,6-epoxy-4,16-dihydroxy-3-methyl-11-[2-(2-oxopyrrolidin-1-yl)ethoxyimino]-3,4,5,6,11,12-hexahydro-1H-2-benzoxacyclotetradecin-1-one
Synonyms:	KF-58333;(1aR,2Z,4E,6E,14R,15aR)-8-Chloro-9,11-dihydroxy-14-methyl-1a,14,15,15a-tetrahydro-6H-oxireno[e][2]benzoxacyclotetradecine-6,12(7H)-dione 6-[O-[2-(2-oxo-1-pyrrolidinyl)ethyl]oxime]
CAS:	308244-21-5
Molecular Formula:	C₂₄H₂₇ClN₂O₇
Molecular Weight:	490.94499
Molecular Structure:
Properties
Safety Data

Other Product

4-[(3-carboxy-2-hydroxy-naphthalen-1-yl)methyl]-3-hydroxy-naphthalene-2-carboxylic acid; 2-[(2R,4E,6E,8R,9R,11R,12S,13S,14R)-12-[(2S,3R,4S,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyl-oxan-2-yl]oxy-4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl]oxy-8-[(2R,5S,6R)-5-dimethylamino-6-methyl-oxan-2-yl]oxy-14-hydroxy-13-methoxy-2,9-dimethyl-16-oxo-1-oxacyclohexadeca-4,6-dien-11-yl]acetaldehyde
2H-Pyran-2-one,5,6-dihydro-6-[(1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11-tridecatetraen-1-yl]-,(6R)-
[6-[6-[[(4E,6Z)-8,14-dihydroxy-13-methoxy-2,9-dimethyl-16-oxo-11-(2-oxoethyl)-1-oxacyclohexadeca-4,6-dien-12-yl]oxy]-4-dimethylamino-5-hydroxy-2-methyl-oxan-3-yl]oxy-4-hydroxy-2,4-dimethyl-oxan-3-yl] acetate
1/C13H19NO2/c1-9(15)6-7-10-8-13(16-14-10)11-4-2-3-5-12(11)13/h11-12H,2-8H2,1H
1/C13H9IO2/c15-13-11-8-4-5-9-12(11)14(16-13)10-6-2-1-3-7-10/h1-9
1/C14H15O3P/c15-18(16-11-13-7-3-1-4-8-13)17-12-14-9-5-2-6-10-14/h1-10,18H,11-12H
11-Octadecenoic acid,3-[(1R,2S,5S,6R,7Z,10S)-2-[(4R,4aS,8aR)-4-[(1E)-2,6-dimethyl-1,5-heptadienyl]-1,4,4a,5,8,8a-hexahydro-6-methoxy-5,8-dioxo-4a-[(10Z)-10-pentadecenyl]-2-naphthalenyl]-1,10-dihydroxy-10-methyl-7-(1-methyl-2-oxoethylidene)spiro[4.5]dec-6-yl]propylester, (11E)- (9CI)
1/C15H13NO/c1-2-16-14-6-4-3-5-12(14)13-9-11(10-17)7-8-15(13)16/h3-10H,2H2,1H
1/C11H14N2O6/c1-17-7(14)4-12-2-3-13-9(10(12)15)8-6(19-13)5-18-11(8)16/h6,8-9H,2-5H2,1H
[(2S,3S,4R,6S)-6-[(2R,3S,4S,5R,6S)-6-[[(2R,4E,6E,8R,9R,11R,12S,13S,14R)-14-acetyloxy-8-hydroxy-13-methoxy-2,9-dimethyl-16-oxo-11-(2-oxoethyl)-1-oxacyclohexadeca-4,6-dien-12-yl]oxy]-4-dimethylamino-5-hydroxy-2-methyl-oxan-3-yl]oxy-4-hydroxy-2,4-dimethyl-oxan-3-yl] 3-methylbutanoate; (2R,3R)-2,3-dihydroxybutanedioic acid
1/C15H18O2/c1-11(16)6-7-12-4-3-5-13-10-14(17-2)8-9-15(12)13/h4,8-10H,3,5-7H2,1-2H
1/C12H16BrIO2/c1-3-5-15-11-8-10(14)12(7-9(11)13)16-6-4-2/h7-8H,3-6H2,1-2H
1/C14H9Br2O2P/c15-11-6-8-13(17-11)19(10-4-2-1-3-5-10)14-9-7-12(16)18-14/h1-9
1/C12H10N4O3/c1-3-19-12(18)10-9(7(2)17)6-14-11-8(4-13)5-15-16(10)11/h5-6H,3H2,1-2H
(R)-6-((1E,3R,4R,6R,7Z,9Z,11E)-3,6-bis((tert-butyldimethylsilyl)oxy)-13-((tert-butyldiphenylsilyl)oxy)-4-hydroxy-3-methyltrideca-1,7,9,11-tetraen-1-yl)-5,6-dihydro-2H-pyran-2-one
1/C11H9N5O/c1-17-6-2-3-8-9(4-6)16-11(14-8)7(5-12)10(13)15-16/h2-4,14H,1H3,(H2,13,15
1H-2-Benzoxacyclotetradecin-1-one,7-(acetyloxy)-3,4,5,6,7,8,9,10-octahydro-14,16-dihydroxy-3-methyl-,[3S-(3R*,7S*,11E)]- (9CI)
1/C15H22O2/c1-10(2)6-5-7-11(3)13-9-14(16)12(4)8-15(13)17/h6,8-9,11,16-17H,5,7H2,1-4H
1/C14H19NO2/c1-3-12-10-17-9-8-15(12)14-7-5-4-6-13(14)11(2)16/h4-7,12H,3,8-10H2,1-2H
1/C14H16O4/c1-5-10-12-9(14(15)18-10)6-7-11(16-4)13(12)17-8(2)3/h5-8,10H,1H2,2-4H